[Short-term fibrinolytic treatment in acute myocardial infarction].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D001809:Blood Viscosity / Q000187:drug effects; D002986:Clinical Trials as Topic; D003374:Coumarins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D010919:Placebos; D013300:Streptokinase / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000925:Anticoagulants; D001593:Benzyl Compounds; D003374:Coumarins; D010919:Placebos; D005340:Fibrinogen; D006493:Heparin; D013300:Streptokinase
Die Kurzzeitfibrinolyse beim akuten Myokardinfarkt.